Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 10—October 2013

Melioidosis in Traveler from Africa to Spain

María I. MorosiniComments to Author , Carmen Quereda, Horacio Gil, Pedro Anda, María Núñez-Murga, Rafael Cantón, and Rogelio López-Vélez
Author affiliations: Author affiliations: Ramón y Cajal University Hospital, Madrid, Spain (M.I. Morosini, C. Quereda, R. Cantón, R. López-Vélez); and National Center for Microbiology, Madrid (H. Gil, P. Anda)

Main Article


Characteristics of reported cases of human melioidosis with African origin*

Patient age, y/sex Area visited/ diagnosed Sample type Final treatment Outcome Clinical risk factors Possible source Method of identification† Reference
64/M Kenya/Denmark Blood, urine, sputum TET+SXT Recovered Pulmonary tuberculosis NR Serology (3)
12/F Sierre Leone/The Gambia/ Bony abscesses CMP+TET No follow-up NR NR Serology (4)
40/F Mauritius Blood CTX+MDZ Died SLE Rainy season API 20NE (5)
58/M Madagascar/La Réunion (France) Sputum IMI Recovered NR Unknown API 20NE, serology, PCR (6)
29/M The Gambia, Guinea Bissau, Senegal]/Spain Soft tissue abscesses CAZ+SXT Recovered Hepatitis
Diabetes Rainy season Vitek II System, API 20NE, PCR (7)
46/F Nigeria/United Kingdom Blood MER No follow-up Diabetes Trip to Nigeria Chromatography, PCR (8)
60/M NR/France Blood IMI+CIP Recovered NR Unknown NR (9)
35/F Madagascar, West Africa/Spain Blood CAZ+DOX Recovered None Goat raw milk ingestion WIDER System,
API 20NE, serology, PCR, MLST This study

*TET, tetracycline; SXT, cotrimoxazole; NR, not reported; CMP, chloramphenicol; CTX, cefotaxime; MDZ, metronidazole; SLE, systemic lupus erythematosus; IMI, imipenem; CAZ, ceftazidime; MER, meropenem; CIP, ciprofloxacin; DOX, doxycycline; MLST, multilocus sequence typing.
†API 20NE, bioMérieux, Marcy l’Étoile, France; Vitek II System, bioMérieux; WIDER system (Fco. Soria-Melguizo, Madrid, Spain).

Main Article

  1. Brilhante  RS, Bandeira  TJ, Cordeiro  RA, Grangeiro  TB, Lima  RA, Ribeiro  JF, Clinical-epidemiological features of 13 cases of melioidosis in Brazil. J Clin Microbiol. 2012;50:3349–52. DOIGoogle Scholar
  2. Meckenstock  R, Therby  A, Marque-Juillet  S, Monnier  S, Khau  D, Pangon  B, Cutaneous melioidosis in adolescent returning from Guadeloupe. Emerg Infect Dis. 2012;18:35960.PubMedGoogle Scholar
  3. Bremmelgaard  A, Bygbjerg  I, Høiby  N. Microbiological and immunological studies in a case of human melioidosis diagnosed in Denmark. Scand J Infect Dis. 1982;14:2715.PubMedGoogle Scholar
  4. Wall  RA, Mabey  DC, Corrah  PT, Peters  L. A case of melioidosis in West Africa. J Infect Dis. 1985;152:424–5. DOIGoogle Scholar
  5. Issack  MI, Bundhun  CD, Gokhool  H. Melioidosis in Mauritius. Emerg Infect Dis. 2005;11:139–40. DOIGoogle Scholar
  6. Borgherini  G, Poubeau  P, Paganin  F, Picot  S, Michault  A, Thibault  F, Melioidosis: an imported case from Madagascar. J Travel Med. 2006;13:318–20. PubMed DOIGoogle Scholar
  7. Cuadros  J, Gil  H, De Miguel  J, Marabé  G, Gómez-Herruz  TA, Lobo  B, Melioidosis imported from West Africa to Europe. Am J Trop Med Hyg. 2011;85:282–4. PubMed DOIGoogle Scholar
  8. Salam  AP, Khan  N, Malnick  H, Kenna  DT, Dance  DA, Klein  JL. Melioidosis acquired by traveler to Nigeria. Emerg Infect Dis. 2011;17:1296–8. PubMed DOIGoogle Scholar
  9. Amezyane  T, Lecoules  S, Algayres  JP. Mycotic iliac aneurysm associated with Burkholderia pseudomallei. Int J Infect Dis. 2010;14(Suppl 3):e381–2. PubMed DOIGoogle Scholar
  10. Karger  A, Stock  R, Ziller  M, Elschner  M, Bettin  B, Melzer  F, Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell matrix-assisted laser desorption/ionisation mass spectrometric typing. BMC Microbiol. 2012;12:229. PubMed DOIGoogle Scholar
  11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. M100–S21. Wayne (PA): The Institute; 2011.
  12. Godoy  D, Randle  G, Simpson  AJ, Aanensen  DM, Pitt  TL, Kinoshita  R, Multilocus typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol. 2003;41:2068–79. PubMed DOIGoogle Scholar
  13. Tamura  K, Dudley  J, Nei  M, Kumar  S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9. PubMed DOIGoogle Scholar
  14. Limmathurotsakul  D, Thammasart  S, Warrasuth  N, Thapanagulsak  P, Jatapai  A, Pengreungrojanachai  V, Melioidosis in animals, Thailand, 2006–2010. Emerg Infect Dis. 2012;18:325–7. PubMed DOIGoogle Scholar
  15. Zong  Z, Wang  X, Deng  Y, Zhou  T. Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the VITEK 2 system. J Med Microbiol. 2012;61:1483–4. PubMed DOIGoogle Scholar

Main Article

Page created: September 16, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.